Statement of Organization, Functions and Delegation of Authority, 24316 [E7-8319]
Download as PDF
<![CDATA[
24316
Federal Register / Vol. 72, No. 84 / Wednesday, May 2, 2007 / Notices
Dated: April 19, 2007.
Daniel C. Schneider,
Acting Assistant Secretary for Children and
Families.
[FR Doc. E7–8318 Filed 5–1–07; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
mmaher on DSK3CLS3C1PROD with $$_JOB
Statement of Organization, Functions
and Delegation of Authority
Notice is hereby given that I have
delegated to the Principal Deputy
Assistant Secretary, Deputy Assistant
Secretaries, Program Directors, Program
Commissioners, Deputy Director/
Commissioner, Office of Child Support
Enforcement, and Staff Office Directors
the following authority vested in me by
the Secretary of Health and Human
Services in the memorandum dated
August 20, 1991, Delegations of
Authority for Social Security Act
Programs; 31 U.S.C. 1535; and HHS
General Administrative Manual,
Chapter 8–77.
(a) Authorities Delegated.
1. Authority to administer approved
cooperative research experimental, pilot
or demonstration projects under the
provisions of sections 1110 and 1115 of
the Social Security Act.
2. Authority to approve interagency
agreements to procure, provide or
exchange services, supplies or
equipment.
(b) Limitations.
1. The authority listed in ι1 above
shall be exercised under the condition
that projects may be administered by the
Office of Planning, Research and
Evaluation (OPRE), by the program/staff
office or jointly by OPRE with the
program/staff office.
2. Where all or any part of an
experimental, pilot, research or
demonstration project is wholly
financed with Federal funds made
available under sections 455(e), 1110 or
1115 of the Social Security Act, without
any State, local or other non-Federal
financial participation, that project must
be approved by the Secretary of Health
and Human Services.
3. This delegation of authority does
not include the authority to approve/
disapprove projects under sections 1110
or 1115 of the Social Security Act or
approve/disapprove waivers of State
Plan requirements or costs that would
not otherwise be included as
expenditures under the provisions of
section 1115(a)(1) and (2) of the Social
Security Act.
VerDate Mar 15 2010
03:08 Aug 19, 2011
Jkt 223001
4. The authority to approve
interagency agreements to procure,
provide, or exchange services, supplies,
or equipment requires the concurrence
of the ACF Chief Financial Officer if it
exceeds $250,000 (including
amendments) within a fiscal year or if
it requires the signature of the Assistant
Secretary, ACF, or the Secretary of HHS.
(c) Effect on Existing Delegations.
As related to this delegation of
authority, this delegation supersedes all
previous delegations of authority
involving the administration of the
cross-program authorities delegated
herein.
(d) Effective Date.
This delegation is effective upon the
date of signature.
I hereby ratify and affirm any actions
taken by the Principal Deputy Assistant
Secretary, Deputy Assistant Secretaries,
Program Directors, Program
Commissioners, Deputy Director/
Commissioner, Office of Child Support
Enforcement, and Staff Office Directors,
which involved the exercise of the
authority delegated herein prior to the
effective date of this delegation.
Dated: April 19, 2007.
Daniel C. Schneider,
Acting Assistant Secretary for Children and
Families.
[FR Doc. E7–8319 Filed 5–1–07; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007D–0135]
Guidance for Industry on Testing of
Glycerin for Diethylene Glycol;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a guidance for industry
entitled ‘‘Testing of Glycerin for
Diethylene Glycol.’’ This guidance
provides recommendations on testing
that will help pharmaceutical
manufacturers, repackers, and other
suppliers of glycerin, and pharmacists
who engage in drug compounding,
avoid the use of glycerin that is
contaminated with diethylene glycol
(DEG) and prevent incidents of DEG
poisoning.
DATES: Submit written or electronic
comments on the guidance by July 31,
2007. General comments on agency
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
guidance documents are welcome at any
time.
Submit written requests for
single copies of the guidance to the
Division of Drug Information (HFD–
240), Center for Drug Evaluation and
Research, Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857. Send one selfaddressed adhesive label to assist that
office in processing your requests.
Submit written comments on the
guidance to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance
document.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Monica Caphart, Center for Drug
Evaluation and Research (HFD–320),
Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,301–
827–9047.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a guidance for industry entitled
‘‘Testing of Glycerin for Diethylene
Glycol.’’ This guidance explains that the
agency recommends that certain
analytical testing procedures be
performed on glycerin to avoid the use
of DEG-contaminated product.
Specifically, the agency is
recommending that all lots of glycerin
received by a pharmaceutical
manufacturing facility undergo identity
testing that includes a test for DEG
content. DEG contamination of glycerin
can be detected by using specific
analytical test procedures described in
the United States Pharmacopeia
monograph for glycerin, which
quantifies the amount of DEG present at
a detection level of 0.1 percent, as
recommended by the interagency
Diethylene Glycol Contamination
Prevention Workshop of 1997.
Repackers, pharmacy compounders, and
others who distribute and prepare
glycerin for use in drug products should
test glycerin that is used, sold for use,
or intended for use in drug products.
This recommendation also applies to
bulk or repackaged glycerin intended as
an excipient or other component for a
drug. In addition, pharmacies that
purchase glycerin for use in
compounding drug products should
either test the glycerin or ensure that
such testing was properly done by a
reliable supplier.
E:\FEDREG\02MYN1.LOC
02MYN1
]]>Agencies
[Federal Register Volume 72, Number 84 (Wednesday, May 2, 2007)]
[Notices]
[Page 24316]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-8319]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Statement of Organization, Functions and Delegation of Authority
Notice is hereby given that I have delegated to the Principal
Deputy Assistant Secretary, Deputy Assistant Secretaries, Program
Directors, Program Commissioners, Deputy Director/Commissioner, Office
of Child Support Enforcement, and Staff Office Directors the following
authority vested in me by the Secretary of Health and Human Services in
the memorandum dated August 20, 1991, Delegations of Authority for
Social Security Act Programs; 31 U.S.C. 1535; and HHS General
Administrative Manual, Chapter 8-77.
(a) Authorities Delegated.
1. Authority to administer approved cooperative research
experimental, pilot or demonstration projects under the provisions of
sections 1110 and 1115 of the Social Security Act.
2. Authority to approve interagency agreements to procure, provide
or exchange services, supplies or equipment.
(b) Limitations.
1. The authority listed in 1 above shall be exercised
under the condition that projects may be administered by the Office of
Planning, Research and Evaluation (OPRE), by the program/staff office
or jointly by OPRE with the program/staff office.
2. Where all or any part of an experimental, pilot, research or
demonstration project is wholly financed with Federal funds made
available under sections 455(e), 1110 or 1115 of the Social Security
Act, without any State, local or other non-Federal financial
participation, that project must be approved by the Secretary of Health
and Human Services.
3. This delegation of authority does not include the authority to
approve/disapprove projects under sections 1110 or 1115 of the Social
Security Act or approve/disapprove waivers of State Plan requirements
or costs that would not otherwise be included as expenditures under the
provisions of section 1115(a)(1) and (2) of the Social Security Act.
4. The authority to approve interagency agreements to procure,
provide, or exchange services, supplies, or equipment requires the
concurrence of the ACF Chief Financial Officer if it exceeds $250,000
(including amendments) within a fiscal year or if it requires the
signature of the Assistant Secretary, ACF, or the Secretary of HHS.
(c) Effect on Existing Delegations.
As related to this delegation of authority, this delegation
supersedes all previous delegations of authority involving the
administration of the cross-program authorities delegated herein.
(d) Effective Date.
This delegation is effective upon the date of signature.
I hereby ratify and affirm any actions taken by the Principal
Deputy Assistant Secretary, Deputy Assistant Secretaries, Program
Directors, Program Commissioners, Deputy Director/Commissioner, Office
of Child Support Enforcement, and Staff Office Directors, which
involved the exercise of the authority delegated herein prior to the
effective date of this delegation.
Dated: April 19, 2007.
Daniel C. Schneider,
Acting Assistant Secretary for Children and Families.
[FR Doc. E7-8319 Filed 5-1-07; 8:45 am]
BILLING CODE 4184-01-P
